Indication
Atypical lobular hyperplasia
1 clinical trial
1 product
2 drugs
Clinical trial
A Phase IIB Randomized Trial of Oral Tamoxifen vs. Topical 4-hydroxytamoxifen Gel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In SituStatus: Recruiting, Estimated PCD: 2026-12-31
Product
Topical 4-OHT gelDrug
VarlilumabDrug
Tamoxifen